$6.63
-0.22-3.21%
At close: Jun 5, 5:00 PM EST
$7.81
1.1817.80%
After Hours: Jun 5, 9:29 AM EST
Seres Therapeutics Inc Earnings Estimates
MCRBNASDAQ
Seres Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:MCRB
Seres Therapeutics (MCRB) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $-2.30 and quarterly revenue of $360.00.
In the most recent quarter (Q1), Seres Therapeutics reported EPS of $-2.08, missing estimates of $-1.85 by 0.12%. Revenue came in at $358.00K, exceeding the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Seres Therapeutics has averaged an EPS surprise of 0.12% and a revenue surprise of 0.93%.
Earnings Date
Aug 5
EPS Estimate
$-2.300
Quarterly Revenue Estimate
$360.00
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$1.15M
Seres Therapeutics Earnings History
Analyze the earnings history of Seres Therapeutics using advanced sorting and filters.
Loading calendar...
Seres Therapeutics (MCRB) Earnings Per Share
The chart below shows Seres Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Seres Therapeutics (MCRB) Revenue
The chart below shows Seres Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?
Seres Therapeutics (MCRB) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
What were the latest earnings per share (EPS) for Seres Therapeutics (NASDAQ:MCRB)?
The Actual EPS was $-2.08, which missed the estimate of $-1.85.
What were Seres Therapeutics’s (NASDAQ:MCRB) revenues?
The Actual Revenue was $358.00K, which beat the estimate of $0.00.
